XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating Expenses        
General, selling and administration $ 106,389 $ 392,110 $ 360,793 $ 1,378,793
Product development costs 1,229,135 309,088 1,446,896 1,526,989
Professional fees 41,256 31,229 507,806 468,463
Loss from Operations 1,376,780 732,427 2,315,495 3,374,245
Other Expenses        
Interest 533,202 507,184 1,577,829 2,590,013
Total other expenses 533,202 507,184 1,577,829 2,590,013
Net loss $ (1,909,982) $ (1,239,611) $ (3,893,324) $ (5,964,258)
Loss per share, basic and diluted $ (0.01) $ (0.00) $ (0.01) $ (0.02)
Weighted average number of shares of common stock outstanding, basic and diluted 294,353,818 268,777,909 278,400,560 252,587,433